O
Orhan Sezer
Researcher at Charité
Publications - 210
Citations - 16540
Orhan Sezer is an academic researcher from Charité. The author has contributed to research in topics: Multiple myeloma & Bortezomib. The author has an hindex of 65, co-authored 210 publications receiving 15295 citations. Previous affiliations of Orhan Sezer include Hackensack University Medical Center & University of Hamburg.
Papers
More filters
Journal ArticleDOI
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
Morie A. Gertz,Raymond L. Comenzo,Rodney H. Falk,Jean Paul Fermand,Bouke P. C. Hazenberg,Philip N. Hawkins,Giampaolo Merlini,Philippe Moreau,Pierre Ronco,Vaishali Sanchorawala,Orhan Sezer,Alan Solomon,Giles Grateau +12 more
TL;DR: A consensus panel was convened comprising 13 specialists actively involved in the treatment of patients with amyloidosis, and a consensus was developed defining each organ involved and the criteria for response.
Journal ArticleDOI
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Antonio Palumbo,S V Rajkumar,Meletios A. Dimopoulos,Paul G. Richardson,J F San Miguel,Bart Barlogie,J L Harousseau,Jeffrey A. Zonder,Michele Cavo,Maurizio Zangari,M. Attal,Andrew Belch,S. Knop,Douglas E. Joshua,Orhan Sezer,Heinz Ludwig,David H. Vesole,J. Bladé,Robert A. Kyle,Jan Westin,Donna M. Weber,Sara Bringhen,Ruben Niesvizky,Anders Waage,M. von Lilienfeld-Toal,Sagar Lonial,Gareth J. Morgan,Robert Z. Orlowski,Kazuyuki Shimizu,KC Anderson,Mario Boccadoro,Brian G.M. Durie,Pieter Sonneveld,Mohamad A. Hussein +33 more
TL;DR: This manuscript summarizes the available evidence and recommends a prophylaxis strategy according to a risk-assessment model for venous thromboembolism (VTE), and recommends low-molecular-weight heparin (LMWH), warfarin or aspirin.
Journal ArticleDOI
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review.
Rafael Fonseca,P L Bergsagel,Johannes Drach,John D. Shaughnessy,Norma C. Gutiérrez,Alexander Keith Stewart,Gareth J. Morgan,B Van Ness,Marta Chesi,Stephane Minvielle,Antonino Neri,Bart Barlogie,W. M. Kuehl,Peter Liebisch,Faith E. Davies,Selina Chen-Kiang,Brian G.M. Durie,Ruben D. Carrasco,Orhan Sezer,Tony Reiman,Linda M. Pilarski,Hervé Avet-Loiseau,Hervé Avet-Loiseau +22 more
TL;DR: In this paper, the authors proposed a framework for the classification of myeloma subtypes and provided recommendations for genetic testing, which needs to be incorporated into daily clinical practice and also as an essential component of all ongoing and future clinical trials.
SPOTLIGHT REVIEW International Myeloma Working Group molecular classification of multiple myeloma: spotlight review
R Fonseca,P L Bergsagel,Johannes Drach,John D. Shaughnessy,Norma C. Gutiérrez,Alexander Keith Stewart,G Morgan,B Van Ness,Marta Chesi,Stephane Minvielle,Antonino Neri,Bart Barlogie,W. M. Kuehl,Peter Liebisch,Faith E. Davies,Selina Chen-Kiang,Ruben D. Carrasco,Orhan Sezer,Tony Reiman,Linda M. Pilarski,Hervé Avet-Loiseau,Samuel Oschin +21 more
TL;DR: It is proposed that genetic testing needs to be incorporated into daily clinical practice and also as an essential component of all ongoing and future clinical trials.
Journal ArticleDOI
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma.
Meletios A. Dimopoulos,Evangelos Terpos,Raymond L. Comenzo,Patrizia Tosi,Meral Beksac,Orhan Sezer,David S. Siegel,Henk M. Lokhorst,Shaji Kumar,S V Rajkumar,Ruben Niesvizky,Lia A. Moulopoulos,Brian G.M. Durie +12 more
TL;DR: Bone scintigraphy has no place in the routine staging of myeloma, whereas sequential dual-energy X-ray absorptiometry scans are not recommended, and Positron emission tomography/CT or MIBI imaging are also not recommended for routine use in the management of Myeloma patients.